Tag: Prescription Drugs
ASA: Intra-Arterial Tenecteplase Beneficial for Large Vessel Occlusion
Improved likelihood of excellent outcome seen with intra-arterial tenecteplase after successful endovascular recanalization
ASA: Alteplase Ups Outcomes at 4.5 to 24 Hours After Symptom Onset in Acute...
Significantly more patients with acute ischemic stroke achieved primary outcome of 0 or 1 on modified Rankin scale at 90 days
Ischemic Stroke Risk Higher With Use of Contemporary Hormonal Contraceptives
Increased risk seen with use of combined pill, progestin-only pills, combined vaginal ring, patch, and progestin-only implant
Offspring of Women With Epilepsy Experience Decreased Bone Metabolism
Exposure to more antiseizure medications also tied to additional issues
Use of Secondary CVD Prevention Medications Low in Most Countries
Use of one or more classes of medications for secondary CVD prevention peaked at 43.1 percent, decreased to 31.3 percent
Lithium Linked to Risk for Thyroid Dysfunction, CKD in Bipolar Disorder
Higher lithium serum levels linked to elevated rates of hypothyroidism, hyperthyroidism, and CKD3+
Age Differences Seen in Efficacy of Type 2 Diabetes Treatments
SGLT2 inhibitors more cardioprotective in older versus younger people despite smaller reduction in HbA1c with older age
ACP Issues Clinical Guideline for Pharmacologic Prevention of Episodic Migraine
Three recommendations suggest monotherapy options for preventing episodic migraine headache in outpatient settings
FDA Approves Wearable Infusion Device for Advanced Parkinson Disease
Onapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease
FDA Approves Susvimo for Diabetic Macular Edema
Approval marks the first and only continuous delivery treatment as an alternate to regular eye injections
